Alverine Citrate 

枸橼酸阿尔维林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAlverine Citrate 
Drug Alias Namealverinum枸橼酸乙双苯丙胺枸橼酸阿尔韦林alverinaAntispasmine +[20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDysmenorrheaIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDysmenorrheaIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeA03AX08